Nephrology Dialysis Transplantation · 2001 · 12 citations · 9 references
Public HealthPhysiologyMicronutrient DeficiencyDisorders Of Calcium MetabolismMagnesium DeficiencyMineral Deficiency Syndromes
Gitelman's syndrome (GS) is a variant of classical Bartter's syndrome (BS) in adults characterized by hypokalaemic metabolic alkalosis, hypocalciuria (daily excretion <2.0 mg/kg body weight), hypomagnesaemia (<1.5 mg/dl), together with a normal to low blood pressure [1]. In 1996, Simon et al. [2] reported complete linkage between the syndrome and the thiazide‐sensitive sodium chloride coporter (TSC) on chromosome 16q13 (Human Gene Mapping Workshop‐approved symbol: SLCA3). Other metabolic features of GS include normonatraemia, hyperuricaemia, normocalcaemia, increased plasma renin and aldosterone/potassium ratio, and inappropriately high renal potassium, magnesium and chloride excretion [3,4]. In this paper, we describe two affected patients who developed severe hyponatraemia and hypouricaemia. To the best of our knowledge, this complication has not been described previously. In 1984, a 27‐year‐old man diagnosed with a psychoaffective disorder and benzodiazepine addiction complained of muscle weakness, tremor and muscular cramps. Routine biochemical analysis showed a serum potassium of 2.42 mmol/l and a serum magnesium of 1.42 mg/dl, together with hyperaldosteronism (31 ng/dl, normal 2–20 ng/dl) and high plasma renin acitvity (22 ng/ml/h, normal 0.3–3.0 ng/ml/h). Twenty‐four‐hour urinary collection showed a high fractional excretion (FE) of chloride (1.6%, normal 0.6–0.8%), hypocalciuria (7.2 mg/24 h), inappropriate kaliuresis (FE K+=26%) and renal magnesium‐wasting despite hypomagnesaemia (FE Mg2+=8.1%, normal 3–5%). Arterial blood gas analysis showed a pH of 7.50 and a plasma HCO−3 of 30 mmol/l. These findings together with his psychiatric history oriented to surreptitious diuretic ingestion, and he was considered as a covert diuretic abuser during recent years. In 1996, his genomic DNA was screened for mutations at Yale University, and two base pair substitutions in the SLC12A3 gene compatible with GS were revealed. A treatment with amiloride, potassium and magnesium supplements was instituted.
9
Marshal Fichman · Annals of Internal Medicine · 1971 · 328 citations
Medicine, Nephrology, Pharmacology +17
Hyponatremia and hypouricemia: differentiation from SIADH.
John K. Maesaka, Vecihi Batuman, Michael Yudd et al. · PubMed · 1990 · 47 citations